Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

Giving obese children weight-loss jabs is effective and helps prevent battles around mealtimes, researchers say. Experts at the European Congress on Obesity in Malaga, Spain, presented findings ...

Landmark' data has revealed a popular weight loss medicine slashes the risk of heart attack, stroke or heart disease death ...

Health experts presented findings showing the drugs helped severely obese youngsters shed pounds on top of the diet and ...

For the first time, scientists have pitted the two most popular weight loss drugs against each other in a direct competition ...

Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

Health and Human Services Secretary Robert F. Kennedy Jr. said that bringing the cost of prescription drugs to levels seen in ...

It found that people on GLP-1 drugs like Wegovy and Ozempic reported eating fewer processed foods, red meat and sugary drinks ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

Mounjaro and Wegovy are two of the biggest names in the world of weight-loss drugs but it's been unclear which is more ...